XML 38 R26.htm IDEA: XBRL DOCUMENT v3.4.0.3
Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2016
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following tables reconcile the components of the numerator and denominator included in the calculations of diluted loss per share:

Three Months Ended March 31,

2016

2015
Numerator



Net loss attributable to Inovio Pharmaceuticals, Inc.
$
(8,042,820
)

$
(10,581,779
)
Reflect adjustment for decrease in fair value of warrant liability


(289,773
)
Numerator for use in diluted loss per share
$
(8,042,820
)

$
(10,871,552
)




Denominator



Weighted average number of common shares outstanding
72,230,411


60,741,082

Effect of dilutive potential common shares


172,341

Denominator for use in diluted loss per share
72,230,411


60,913,423


 
 
 
Net loss per share, diluted
$
(0.11
)
 
$
(0.18
)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes potential common shares that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect for the three months ended March 31, 2016 and 2015:
 
 
Common Stock Equivalents
2016
 
2015
Options to purchase common stock
7,135,624

 
5,930,767

Warrants to purchase common stock
560,904

 
727,969

Restricted stock units
732,668

 
130,000

Convertible preferred stock
8,456

 
8,456

Total
8,437,652

 
6,797,192